Our analyses of the FDA data showed relatively little…
““Our analyses of the FDA data showed relatively little difference between the effects of antidepressants and the effects of placebos. Indeed, the effects were so small that they did not qualify as clinically significant. The drug companies knew how small the effect of their medications were compared to placebos, and so did the FDA and other regulatory agencies. The companies found various ways to make the data seem more favorable to their products, and the FDA helped them keep their negative data secret. In fact, in some instances, the FDA urged the companies to keep negative data hidden, even when the companies wanted to reveal them. My colleagues and I hadn't really discovered anything new. We had merely revealed their 'dirty little secret'.””
About This Quote
This interpretation was drafted with AI assistance. It is one reading of the quote, not the author's own explanation.
Data show antidepressants' effects are minimal, often not clinically significant, with regulatory concealment of negative results.
In simple terms: Antidepressants may not work better than placebos, and data were hidden.
Key Takeaway
Question the efficacy and transparency of drug approvals.
Themes
science
ethics
medicine
regulation
transparency
Mood
skeptical
concerned
Type
critical
analytical
When to use this quote
- patient care
- policy making
- pharmaceutical research
- public health advocacy
Key Concepts
placebo effect
clinical significance
industry bias
regulatory capture
Questions to Reflect On
- What alternative therapies could be explored?
- How can patients be better informed?
A Different Perspective
Complexities of mental health treatment may require nuanced approaches beyond medication.